Macrophage activation assay

MM M. Rezaa Mohammadi
SR Samuel Mathew Rodriguez
JL Jennifer Cam Luong
SL Shiri Li
RC Rui Cao
HA Hamad Alshetaiwi
HL Hien Lau
HD Hayk Davtyan
MJ Mathew Blurton Jones
MJ Mahtab Jafari
KK Kai Kessenbrock
SV S. Armando Villalta
PV Paul de Vos
WZ Weian Zhao
JL Jonathan R. T. Lakey
ask Ask a question
Favorite

RAW 264.7 cells were purchased from ATCC (CAT# TIB-71) and NFκB reporter THP-1_Lucia human cell lines were purchased from InvivoGen (CAT#: thpl-nfkb) employed for downstream experiments of this study. Passages 5–10 were cultured in RPMI 1640 supplemented with 10% of heat-inactivated FBS in the presence of 1% penicillin/streptomycin and 1% L-glutamine. Cells were then stimulated with 10 or 100 ng/mL of LPS (Invitrogen, CAT#: 50-112-2025). Stimulated and non-stimulated cells were then mixed with XOs with the mentioned concentrations in the results section. Control cells, LPS-stimulated cells in the presence and absence of XOs, and non-stimulated cells in the presence and absence of XOs (100,000 cells for each condition) were co-cultured for 10–14 h at 37 °C in a humidified incubator with 5% CO2. Next, supernatant was collected for cytokine analyses. Supernatants were centrifuged at 2500 × g and 4 °C for 5 min and stored at −80 °C. Samples were then shipped on dry ice to Eve Technologies (Calgary, Canada), where cytokines were analyzed using Mouse Focused 32-Plex Discovery Assay (CAT#: 17619).

Do you have any questions about this protocol?

Post your question to gather feedback from the community. We will also invite the authors of this article to respond.

post Post a Question
0 Q&A